Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Molecular Models02:00

Molecular Models

43.2K
Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
43.2K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.6K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrative In Silico and In Vivo Evidence of Quercetin as a Multitarget Neuroprotective Agent in Alzheimer's Disease.

ACS omega·2026
Same author

Silodosin as a Novel Inhibitor of Acetylcholinesterase, Butyrylcholinesterase, and BETA-Secretase 1: In Vitro and In Silico Studies.

ACS omega·2025
Same author

Trihydroxyflavanone isolated from Dipteryx lacunifera Ducke (Fabaceae) as a potential antimalarial drug: An in silico and in vitro approach.

Anais da Academia Brasileira de Ciencias·2025
Same author

Identification of Potential Multitarget Compounds against Alzheimer's Disease through Pharmacophore-Based Virtual Screening.

Pharmaceuticals (Basel, Switzerland)·2023
Same author

Development of Potential Multi-Target Inhibitors for Human Cholinesterases and Beta-Secretase 1: A Computational Approach.

Pharmaceuticals (Basel, Switzerland)·2023
Same author

Evaluation of antiplasmodial activity in silico and in vitro of N-acylhydrazone derivatives.

BMC chemistry·2022

Related Experiment Video

Updated: Dec 24, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.0K

Molecular Architect: A User-Friendly Workflow for Virtual Screening.

Eduardo H B Maia1,2, Lucas Rolim Medaglia3, Alisson Marques da Silva2

  • 1Laboratório de Quêmica Farmaĉutica Medicinal, Universidade Federal de São João Del-Rei, Divinópolis 35501-296, Minas Gerais, Brazil.

ACS Omega
|April 8, 2020
PubMed
Summary

Molecular Architect (MolAr) simplifies virtual screening (VS) for drug discovery. This integrated workflow automates complex processes, making VS more accessible and effective for identifying potential drug candidates.

More Related Videos

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

987
Modeling an Enzyme Active Site using Molecular Visualization Freeware
14:37

Modeling an Enzyme Active Site using Molecular Visualization Freeware

Published on: December 25, 2021

11.1K

Related Experiment Videos

Last Updated: Dec 24, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.0K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

987
Modeling an Enzyme Active Site using Molecular Visualization Freeware
14:37

Modeling an Enzyme Active Site using Molecular Visualization Freeware

Published on: December 25, 2021

11.1K

Area of Science:

  • Computational chemistry and cheminformatics
  • Drug discovery and development
  • Bioinformatics and computational biology

Background:

  • Computer-assisted drug design (CADD) aids new drug development.
  • Virtual screening (VS) identifies drug-like molecules but existing tools are complex and fragmented.
  • Current VS tools often require advanced computational skills and manual data processing, increasing error potential.

Purpose of the Study:

  • To develop Molecular Architect (MolAr), an integrated and automated workflow for the entire virtual screening process.
  • To provide a user-friendly interface that simplifies complex CADD tasks.
  • To enhance the efficiency and accuracy of virtual screening in drug discovery.

Main Methods:

  • MolAr integrates protein preparation (homology modeling, protonation) and virtual screening.
  • It utilizes AutoDock Vina, DOCK 6, or a consensus approach for VS.
  • The workflow was validated through two case studies, including DNA-ligand systems and the DUD-E database.

Main Results:

  • MolAr demonstrated effective virtual screening for DNA-ligand systems, with consensus VS showing superior predictive performance.
  • Using AutoDock Vina results as input for DOCK 6 improved DOCK 6's ROC curves by up to 42% in a second case study.
  • These results confirm MolAr's capability in conducting the VS process effectively.

Conclusions:

  • MolAr is an easy-to-use and effective tool for computer-assisted drug design.
  • The integrated and automated nature of MolAr streamlines the virtual screening workflow.
  • MolAr facilitates the identification of potential drug candidates, making VS more accessible to researchers.